Trial Profile
Dual Trigger Versus Gonadotropin Releasing Hormone Agonist Trigger Combined With Luteal Human Chorionic Gonadotropin Administration
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2023
Price :
$35
*
At a glance
- Drugs Chorionic gonadotropin (Primary) ; Triptorelin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 27 Oct 2023 Planned End Date changed from 1 Mar 2021 to 31 Dec 2024.
- 27 Oct 2023 Planned primary completion date changed from 1 Jan 2021 to 31 Dec 2024.
- 24 Apr 2020 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.